Document is current
Any future updates will be listed below
-
Authors
Kopp, Anja https://orcid.org/0000-0001-5484-7109
Hagelueken, Gregor https://orcid.org/0000-0001-8781-5664
Jamitzky, Isabell https://orcid.org/0000-0001-9449-2015
Moecking, Jonas https://orcid.org/0000-0001-5914-1359
Schiffelers, Lisa D. J. https://orcid.org/0000-0003-2301-1610
Schmidt, Florian I. https://orcid.org/0000-0002-9979-9769
Geyer, Matthias https://orcid.org/0000-0002-7718-5002
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC2151–390873048, GRK 2168)
- License Information
-
More Information
Article History
Received: 18 April 2023
Accepted: 16 November 2023
First Online: 1 December 2023
Competing interests
: F.I.S. is cofounder and shareholder of Odyssey Therapeutics. The other authors declare no competing interests.
